European Testing Week media centre
You will also find factsheets for participants to populate with regional statistics in order to support media outreach activities. For guidance to help you with any media activities, you may wish to refer to Toolkit 2 – testing week implementation handbook available for download.
Read our latest newsletters informing participants and others of the latest news, updates and ongoing activities. You can also browse the newsletters from previous years to see what was achieved in previous years.
- 12/05/2022 - Counting down to the Spring #EuroTestWeek, 16 – 23 May 2022
- 04/04/2022 - Spring 2022 #EuroTestWeek + New website launch!
- 21/01/2022 - Participate in the 2021 EuroTEST COVID-19 impact survey
- 17/01/2022 - Evaluation deadline for 2021 November ETW extended
- 15th December 2021
- 18th November 2021
- 3rd November 2021
- 2nd June 2021
- 31st May 2021
- 14th May 2021
- 28th April 2021
- 9th December 2020
- 1st December 2020
- 19th November 2020
- 30th October 2020
- 11th September 2020
- 27th July 2020
- 25th May 2020
- 15th May 2020
- 8th May 2020
- 6th April 2020
- 26th February 2020
- 27th January 2020
On November 29 2021, International and European Testing Week have launched a Joint Press Release about the critical decline in testing for HIV, hepatitis and STIs, caused by the Covid-19 pandemic, and about the International and European Testing Week initiative which focus on increasing access to testing and raising awareness about the importance of early testing.
Read the press release here.
To mark the start of European Testing Week (23-30 November 2018), the European Centre for Disease Prevention and Control has published their new public health guidance on integrated testing for HBV, HCV and HIV testing in the EU/EEA. The new guidance provides testing strategies based on the latest scientific evidence for national or local hepatitis B, C and HIV testing guidelines and programmes.
The HIV in Europe and ETW initiatives have published a press release commending ECDC for recognising the importance of combined viral hepatitis and HIV testing efforts and calls upon the European community to implement the new guidance into national context and policies.